Cefpodoxime 200mg. with Clavulanic Acid 125mg.


Prevention of resistance to Cefpodoxime which may increase over a period of time due to its extensive use

Cefpodoxime-Clavulanic acid combination has the unique property of a broad spectrum antibiotic with the added advantage of a wide spectrum beta lactamase inhibitor

Highly effective combination in SWITCH THERAPY

Helps in
  • Upper respiratory tract infections
  • Acute exacerbation of chronic bronchitis
  • Acute community acquired pneumonia
  • Acute uncomplicated gonorrhoea
  • Uncomplicated uninary tract infections
  • Skin & skin infections
  • Interested in woking with us?

    We provide high standard medicine at great price